Correlation Between BioAffinity Technologies, and Vivos Therapeutics

Can any of the company-specific risk be diversified away by investing in both BioAffinity Technologies, and Vivos Therapeutics at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining BioAffinity Technologies, and Vivos Therapeutics into the same portfolio, which is an essential part of the fundamental portfolio management process.

By analyzing existing cross correlation between bioAffinity Technologies, and Vivos Therapeutics, you can compare the effects of market volatilities on BioAffinity Technologies, and Vivos Therapeutics and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in BioAffinity Technologies, with a short position of Vivos Therapeutics. Check out your portfolio center. Please also check ongoing floating volatility patterns of BioAffinity Technologies, and Vivos Therapeutics.

Diversification Opportunities for BioAffinity Technologies, and Vivos Therapeutics

0.48

Correlation Coefficient

BioAffinity Technologies,  Vivos Therapeutics

Very weak diversification

The 3 months correlation between BioAffinity and Vivos is 0.48. Overlapping area represents the amount of risk that can be diversified away by holding bioAffinity Technologies, and Vivos Therapeutics in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Vivos Therapeutics and BioAffinity Technologies, is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on bioAffinity Technologies, are associated (or correlated) with Vivos Therapeutics. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Vivos Therapeutics has no effect on the direction of BioAffinity Technologies, i.e., BioAffinity Technologies, and Vivos Therapeutics go up and down completely randomly.

Pair Corralation between BioAffinity Technologies, and Vivos Therapeutics

Given the investment horizon of 90 days bioAffinity Technologies, is expected to generate 1.49 times more return on investment than Vivos Therapeutics. However, BioAffinity Technologies, is 1.49 times more volatile than Vivos Therapeutics. It trades about 0.09 of its potential returns per unit of risk. Vivos Therapeutics is currently generating about 0.11 per unit of risk. If you would invest  22.00  in bioAffinity Technologies, on May 13, 2025 and sell it today you would earn a total of  7.00  from holding bioAffinity Technologies, or generate 31.82% return on investment over 90 days.

Time Period	3 Months [change]
Direction	Moves Together
Strength	Weak
Accuracy	100.0%
Values	Daily Returns

bioAffinity Technologies,  vs.  Vivos Therapeutics

bioAffinity Technologies,

Risk-Adjusted Performance

Mild

Compared to the overall equity markets, risk-adjusted returns on investments in bioAffinity Technologies, are ranked lower than 6 (%) of all global equities and portfolios over the last 90 days. Despite nearly fragile basic indicators, BioAffinity Technologies, reported solid returns over the last few months and may actually be approaching a breakup point.

Vivos Therapeutics

Risk-Adjusted Performance

Fair

Compared to the overall equity markets, risk-adjusted returns on investments in Vivos Therapeutics are ranked lower than 8 (%) of all global equities and portfolios over the last 90 days. In spite of comparatively fragile basic indicators, Vivos Therapeutics unveiled solid returns over the last few months and may actually be approaching a breakup point.

Pair Trading with BioAffinity Technologies, and Vivos Therapeutics

The main advantage of trading using opposite BioAffinity Technologies, and Vivos Therapeutics positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if BioAffinity Technologies, position performs unexpectedly, Vivos Therapeutics can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Vivos Therapeutics will offset losses from the drop in Vivos Therapeutics' long position.

The idea behind bioAffinity Technologies, and Vivos Therapeutics pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.

Check out your portfolio center.

Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Pair Correlation module to compare performance and examine fundamental relationship between any two equity instruments.